1-Methylindole-6-carbaldehyde structure
|
Common Name | 1-Methylindole-6-carbaldehyde | ||
---|---|---|---|---|
CAS Number | 21005-45-8 | Molecular Weight | 159.18500 | |
Density | 1.1g/cm3 | Boiling Point | 318.7ºC at 760mmHg | |
Molecular Formula | C10H9NO | Melting Point | 81ºC | |
MSDS | Chinese USA | Flash Point | 146.5ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | 1-Methylindole-6-carbaldehyde |
---|---|
Synonym | More Synonyms |
Density | 1.1g/cm3 |
---|---|
Boiling Point | 318.7ºC at 760mmHg |
Melting Point | 81ºC |
Molecular Formula | C10H9NO |
Molecular Weight | 159.18500 |
Flash Point | 146.5ºC |
Exact Mass | 159.06800 |
PSA | 22.00000 |
LogP | 1.99080 |
Vapour Pressure | 0.000356mmHg at 25°C |
Index of Refraction | 1.585 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H319-H412 |
Precautionary Statements | P273-P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |
HS Code | 2933990090 |
~78% 1-Methylindole-... CAS#:21005-45-8 |
Literature: Wang, Guangcheng; Li, Chunyan; He, Lin; Lei, Kai; Wang, Fang; Pu, Yuzi; Yang, Zhuang; Cao, Dong; Ma, Liang; Chen, Jinying; Sang, Yun; Liang, Xiaolin; Xiang, Mingli; Peng, Aihua; Wei, Yuquan; Chen, Lijuan Bioorganic and Medicinal Chemistry, 2014 , vol. 22, # 7 p. 2060 - 2079 |
~24% 1-Methylindole-... CAS#:21005-45-8 |
Literature: AFFINIUM PHARMACEUTICALS, INC. Patent: WO2007/53131 A2, 2007 ; Location in patent: Page/Page column 157 ; WO 2007/053131 A2 |
~% 1-Methylindole-... CAS#:21005-45-8 |
Literature: US5891901 A1, ; |
~% 1-Methylindole-... CAS#:21005-45-8 |
Literature: Journal of Organometallic Chemistry, , vol. 696, # 5 p. 1072 - 1083 |
~% 1-Methylindole-... CAS#:21005-45-8 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 34, # 10 p. 4109 - 4115 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Rational design of novel CYP2A6 inhibitors.
Bioorg. Med. Chem. 22(23) , 6655-64, (2015) Inhibition of CYP2A6-mediated nicotine metabolism can reduce cigarette smoking. We sought potent and selective CYP2A6 inhibitors to be used as leads for drugs useful in smoking reduction therapy, by e... |
1-Methyl-1H-indole-6-carbaldehyde |
1-methyl-1H-indole-6-carbaldehyde |
6-formyl-1-methylindole |
N-methyl-6-indolecarboxaldehyde |
1-methyl-indole-6-carboxaldehyde |
1-methyl-6-indolecarbaldehyde |
1-Methyl-1H-indole-6-carboxaldehyde |
1-methyl-1H-indole-6-carboxaldehyde |